STEPHEN ROZIER: Open Payments
NPI 1255645362 · AIKEN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 20 payments from 9 companies in 2025. Trend: 2023 $1,073 · 2024 $861 · 2025 $502
Food & beverage: $419Education: $83
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $140 |
| Janssen Biotech, Inc. | 3 | $120 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $90 |
| PFIZER INC. | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| GENZYME CORPORATION | 1 | $24 |
| Verrica Pharmaceuticals Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
| UCB, Inc. | 1 | $17 |
Products named: SKYRIZI, TREMFYA, ILUMYA, DUPIXENT, CIBINQO, YCANTH, TALTZ, Bimzelx.
Industry payments across SC — which companies pay providers there.
